RE:INSIDERS NEED TO STEP IN TO STEP UPSimply put..........MOM has to walk the talk.
If you look at the news releases over the last few years, there is a cycle of talk and no walk. A lot of promises but no revenue. If the stock price was based on the number of PP's this stock would be trading at $10/share.
If anyone is going to the AGM a question on PreVU's performance would be appropriate. Approvals, letters of intent, drug store forecasts, WHY no revenue? What is MOM doing to avoid the SCOUT falling under the same NO WALK designation as PreVU?